Anjan Thakurta

9PUBLICATIONS
64CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyHaematological tumoursGene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 21, 2026
Understanding and addressing resistance to IMiDs immunomodulatory compounds in multiple myeloma.

|Nov 07, 2023
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma.

Paola Neri, Benjamin G Barwick, David Jung

|Jan 05, 2023
High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma.

Mehmet Kemal Samur, Marco Roncador, Anil Aktas Samur

|Aug 19, 2022
The location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of patients with high-risk NDMM.

Nicholas Stong, María Ortiz-Estévez, Fadi Towfic

|Aug 12, 2022
Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine.

Hartmut Döhner, Andrew H Wei, Gail J Roboz

|Jul 19, 2022
Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma.

Sarah Gooding, Naser Ansari-Pour, Mohammad Kazeroun

Pageof 2

Frequent Collaborators

2 joint publications

Fadi Towfic

2 joint publications

Jill Corre

2 joint publications

Karthik Ramasamy

2 joint publications

Sarah Gooding